News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis International AG (NVS) Proposes Changes to Galvus Prescribing


11/6/2007 12:38:56 AM

ZURICH (Reuters) - Swiss drugmaker Novartis AG has proposed changes to European prescribing information for its Galvus diabetes medicine, after finding safety problems with higher doses. Novartis made the recommendations after giving a safety update to European regulators and said on Tuesday it would also discuss the data and recommendations with other regulators.

Read at Reuters

comments powered by Disqus
Reuters
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES